Blood cleansing device removes pathogens
Path Ex, a small business funded by the National Science Foundation (NSF), is developing a device to remove pathogens from blood.
Path Ex’s device can selectively remove pathogens and treat drug-resistant bacteria and endotoxins from circulating...
You are here
Path Ex, Inc.
Company Information
Information
UEI: XFGZXJB2PC49
# of Employees: 2
Ownership Information
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: Yes
Award Charts
Award Listing
-
SBIR Phase II: Rapid Blood Cleansing Device to Combat Infection
Amount: $750,000.00The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project will be the development of a fluidic platform for selective bacterial and endotoxin removal f ...
SBIRPhase II2018National Science Foundation -
STTR Phase I: Rapid Blood Cleansing Device to Combat Infection
Amount: $225,000.00The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to develop a dialysis-like platform for selective bacterial separation and removal from blo ...
STTRPhase I2017National Science Foundation